Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126713581 | 12671358 | 1 | I | 20160615 | 20160615 | 20160822 | 20160822 | PER | US-TEVA-670672USA | TEVA | 60.02 | YR | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126713581 | 12671358 | 1 | PS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Oral | Y | 6BE1128 (43F397) | 76191 | 180 | MG | TABLET | ||||||
| 126713581 | 12671358 | 2 | C | ZONISAMIDE. | ZONISAMIDE | 1 | 0 | ||||||||||||
| 126713581 | 12671358 | 3 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126713581 | 12671358 | 1 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126713581 | 12671358 | Drug ineffective | |
| 126713581 | 12671358 | Headache | |
| 126713581 | 12671358 | Nausea | |
| 126713581 | 12671358 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126713581 | 12671358 | 1 | 20160615 | 20160615 | 0 | |
| 126713581 | 12671358 | 2 | 2013 | 0 | ||
| 126713581 | 12671358 | 3 | 2013 | 0 |